Peter Gennemark
Adjunct Associate Professor, Docent
My research aims to improve understanding of diabetes and cardiovascular disease and their treatment, by mathematical modelling.
Systems pharmacology – a pharma industry collaboration
Peter Gennemark (Principal scientist at AstraZeneca, Gothenburg, Sweden) is adjunct senior lecturer at IMT. Peter has an established collaboration in systems pharmacology with Gunnar Cedersund (IMT). His research is directed towards systems pharmacology in the diabetes and cardiovascular disease areas, with the aim of increasing knowledge of biology, disease progression and drug intervention in these areas.